Lloyds Banking Group is to buy out Schroders’ 49.9% stake in their UK wealth joint venture, the companies said on Thursday, as the British bank looks to expand in the so-called ‘mass affluent’ sector...
Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push
Drugmaker Bristol Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to diversify from legacy products facing competition from generic...
RedBird Capital formally requests approval for acquisition of UK’s Telegraph
RedBird Capital Partners on Friday formally requested approval from the British government to proceed with its proposed acquisition of The Telegraph, according to an internal memo seen by Reuters and confirmed by the U...
Strathcona exits race for MEG Energy after Cenovus’ sweetened bid
Strathcona Resources on Friday abandoned its takeover bid for MEG Energy, ending its months-long battle with Cenovus Energy for the ownership of one of Canada’s last large pure-play oil sands company. The move by...
Johnson & Johnson in talks to acquire Protagonist Therapeutics, source says
Johnson & Johnson is in discussions to buy Protagonist Therapeutics, a source familiar with the matter told Reuters. Shares of Protagonist surged more than 30% in afternoon trading. The company had a market...
Porr acquires parts of Fresenius’ VAMED as Strabag pulls out
Construction company Porr will acquire the Austrian project development business of VAMED and the Austrian thermal spa holdings from Fresenius as Austria’s Strabag withdrew from the deal, the companies said on...
Prosus buys 10% stake in Ixigo parent for Rs 1,295 crore; travel site to use funds for expansion
The board of Le Travenues Technology, the parent of online travel aggregator Ixigo, has approved a primary investment of Rs 1,295 crore by Dutch investment firm Prosus (MIH Investments One B.V.) for a 10.1% stake in the...
Novo to buy Akero for up to $5.2 billion in new CEO’s revival push
Novo Nordisk said on Thursday it would buy U.S.-based Akero Therapeutics for up to $5.2 billion to gain access to a promising liver disease drug candidate, in the first major deal by the Danish drugmaker’s new CEO...
Aramco completes deal to up stake in struggling JV Petro Rabigh
Saudi Aramco said on Thursday it had completed the acquisition of a 22.5% stake in its refining and petrochemicals joint venture Petro Rabigh from Japan’s Sumitomo Chemical for 2.63 billion riyals ($701.8...
Life sciences companies may turn to spin-offs to avoid sell-offs
Big Pharma continues its hunt for innovation, and with uncertain market and regulatory conditions, some life sciences companies may be feeling the pressure to make their M&A exit or need additional funding in this...
Softbank’s PayPay buys 40% stake in Binance’s Japan to deepen push into digital payments
SoftBank’s payments app operator PayPay Corp has acquired a 40% equity stake in Binance Japan, the Japanese subsidiary of Binance said on Thursday, without disclosing details of the transaction. PayPay is the...
Lloyds to buy Schroders’ stake in UK wealth joint venture
Lloyds Banking Group is to buy out Schroders’ 49.9% stake in their UK wealth joint venture, the companies said on Thursday, as the British bank looks to expand in the so-called ‘mass affluent’ sector...
